Exploratory assessment of the current EU regulatory framework for development of advanced therapies

Author： Singh Pawanbir   Brévignon-Dodin Laure   Dash Satya P  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.16, Iss.4, 2010-10, pp. : 331-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EU Legal and Regulatory Update

By  

Journal of Commercial Biotechnology, Vol. 17, Iss. 2, 2011-05 ,pp. : 183-189

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

EU Legal and Regulatory Update

By  

Journal of Commercial Biotechnology, Vol. 17, Iss. 1, 2011-02 ,pp. : 109-120

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

US and EU legal and regulatory update

By  

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 242-252

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The regulatory system in the EU and further afield

By Kinderlerer Julian  

Journal of Commercial Biotechnology, Vol. 10, Iss. 3, 2004-03 ,pp. : 248-257

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Negotiating the precautionary principle: regulatory and institutional roots of divergent US and EU positions

By Konig Ariane  

International Journal of Biotechnology, Vol. 4, Iss. 1, 2003-07 ,pp. : 61-80

Inderscience Publishers

Access to resources Recommend Favorite